| 1 |
35297512 | Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases. | 2022 Jun |
5 |
| 2 |
35536531 | Tofacitinib enhances IGF1 via inhibiting STAT6 transcriptionally activated-miR-425-5p to ameliorate inflammation in RA-FLS. | 2022 May 10 |
1 |
| 3 |
33317858 | Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib. | 2021 May |
1 |
| 4 |
33491334 | Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad. | 2021 Mar |
7 |
| 5 |
33705988 | Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium. | 2021 May |
1 |
| 6 |
33899926 | Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis. | 2021 Aug |
1 |
| 7 |
34107055 | Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein. | 2021 Sep |
2 |
| 8 |
34173094 | The Effect of Janus Kinase Inhibitors and Phosphodiesterase-4 Inhibitors on Skin and Plasma Cytokine Levels in Patients with Psoriasis. | 2021 May |
1 |
| 9 |
34226674 | Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis. | 2021 Sep |
1 |
| 10 |
34757416 | Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis. | 2021 Dec 1 |
1 |
| 11 |
34868078 | Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review. | 2021 |
1 |
| 12 |
31605536 | Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo. | 2020 Apr |
1 |
| 13 |
31721311 | The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development. | 2020 Jan |
1 |
| 14 |
31751457 | The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction. | 2020 Feb 11 |
3 |
| 15 |
32695877 | Attenuation of Dupuytren's fibrosis via targeting of the STAT1 modulated IL-13Rα1 response. | 2020 Jul |
1 |
| 16 |
33031288 | Herpes Zoster in rheumatoid arthritis patients receiving tofacitinib, a single center experience from Taiwan. | 2020 Oct 9 |
1 |
| 17 |
30846331 | Interferon-γ upregulates Δ42PD1 expression on human monocytes via the PI3K/AKT pathway. | 2019 May |
1 |
| 18 |
31173242 | Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancer. | 2019 Aug |
1 |
| 19 |
31780862 | Changes in Serum Cytokines May Predict Therapeutic Efficacy of Tofacitinib in Rheumatoid Arthritis. | 2019 |
1 |
| 20 |
28513593 | Jak3 deficiency blocks innate lymphoid cell development. | 2018 Jan |
1 |
| 21 |
29254929 | Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis. | 2018 May 1 |
1 |
| 22 |
30002661 | Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System. | 2018 |
1 |
| 23 |
28754958 | A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis. | 2017 Jul 28 |
1 |
| 24 |
29225517 | Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy. | 2017 |
1 |
| 25 |
29268845 | [Inhibitory effect and mechanism of tofacitinib on the secretion of cytokines by T cells in human peripheral blood]. | 2017 Nov |
3 |
| 26 |
26689752 | Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation. | 2016 Apr |
2 |
| 27 |
24213371 | Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib. | 2014 Apr |
1 |
| 28 |
23274966 | Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. | 2013 Feb 15 |
1 |
| 29 |
22147632 | The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells. | 2012 Jun |
3 |
| 30 |
22460142 | In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis. | 2012 Apr |
1 |
| 31 |
20697326 | CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway. | 2010 Oct 27 |
4 |
| 32 |
19136895 | The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients. | 2009 Jan 15 |
1 |